Setting process control limits for enzyme tests in serum

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 59, Issue 7, 1999, Pages 527-530

  Lott, John ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Laboratory variability; Medical needs criteria; Proficiency testing; Quality control; Reference sample method

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; AMYLASE; CREATINE KINASE; LACTATE DEHYDROGENASE;

ACCURACY; DATA ANALYSIS; ENZYME ASSAY; ENZYME BLOOD LEVEL; INTERMETHOD COMPARISON; LABORATORY; PRIORITY JOURNAL; QUALITY CONTROL; REFERENCE VALUE; REVIEW;

EID: 0033388144     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365519950185283     Document Type: Review

References (17)

1. 1 Lott JA, Smith DA, Mitchell L, Moeschberger ML. Use of medians and "average of normals" of patients' data for assessment of long-term analytical stability. Clin Chem 1996; 42: 888-92.
2. 2 Lott JA. Process control and method evaluation. In: Snyder JR, Wilkinson DS, editors. Management in laboratory medicine, 3rd ed. Philadelphia: Lippencott-Raven, 1998: 293-326.
3. 3 Westgard JO, Barry PL, Hunt MR, Groth T. A multi-rule Shewhart chart for quality control in clinical chemistry. Clin Chem 1981; 27: 493-501.
4. 4 Lindberg DAB, Watson FR. Imprecision of laboratory determinations and diagnostic accuracy: theoretical considerations. Method Inform Med 1974; 13: 151-8.
5. 5 Sunderman FW Jr. Current concepts of "normal values", "reference values", and "discrimination value" in clinical chemistry. Clin Chem 1975; 21: 1873-7.
6. 6 Tonks DB. A study of the accuracy and precision of clinical chemistry determinations in 170 Canadian laboratories. Clin Chem 1963; 9: 217-33.
7. 7 Skendzel LP. How physicians use laboratory tests. JAMA 1978; 293: 1077-80.
8. 8 Skendzel LP, Barnett RN, Platt R. Medically useful criteria for analytic performance of laboratory tests. Am J Clin Pathol 1985; 83: 200-5.
9. 9 Lott JA, Surufka N, Massion CG. Proficiency testing of serum enzymes based on medical-needs criteria. Arch Pathol Lab Med 1991; 115: 11-4.
10. 10 Fraser CG. The application of theoretical goals based on biological variation data in proficiency testing. Arch Pathol Lab Med 1988; 112: 404-15.
11. 11 Siest G, Schiele F, Henny J, Young DS. Interpretation of clinical laboratory tests. Reference values and their biological variation. Foster City, CA: Biomedical Publications, 1985.
12. 12 Fraser CG, Petersen PH. Desirable standards for laboratory tests if they are to fulfill medical needs. Clin Chem 1993; 39: 1447-55.
13. 13 Boyle CE, Cummings ST, Fraser CG. Amylase versus lipase activity assays: considerations from biological variation. Ann Clin Biochem 1987; 24 Suppl 1: 37-8.
14. 14 Health Care financing Administration, Medicare, Medicaid and CLIA programs: revision of laboratory regulations; final rule with request for comments. Fed Regist 1990; 55: 9538-610.
15. 15 Laessig RH, Ehrmeyer SS, Leinweber JE. Intralaboratory performance requirements necessary to pass proficiency testing: CAP 1990 vs. CLIA 1967 (March 14, 1990) formats compared. Clin Chem 1992; 38: 895-903.
16. 16 Fraser CG, Petersen PH. The importance of imprecision. Ann Clin Biochem 1991; 28: 207-11.
17. 17 Ehrmeyer SS, Laessig RH, Leinweber JE, Oryall JJ. Medicare/CLIA final rules for proficiency testing: minimum intralaboratory performance characteristics (CV and bias) needed to pass. Clin Chem 1990; 36: 1736-40.